Form 4: Surgery Partners Executive Acquires Shares Through Restricted Stock Award
SEC Form 4 Filing
William Trenton Webb, American Group President at Surgery Partners, acquired 1,877 shares of common stock through a restricted stock award on September 1, 2024.
Summary
- On September 1, 2024, William Trenton Webb, American Group President of Surgery Partners, Inc., acquired 1,877 shares of common stock.
- The acquisition was a result of a restricted stock award (RSA) granted on the same date.
- The price per share was $31.95.
- The RSAs vest in three equal annual installments starting on the first anniversary of the grant date.
- Following the transaction, Webb directly owns 57,380 shares of Surgery Partners, Inc.
- The transaction was reported on September 4, 2024.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine transaction related to executive compensation. The acquisition of shares by an executive is generally viewed as a positive signal, but it's not a major event.
Positives
- The acquisition of shares by a company executive can be seen as a positive sign, indicating confidence in the company's future performance.
Future Outlook
The restricted stock awards vest in three equal annual installments, suggesting a multi-year alignment of the executive's interests with the company's performance.
Industry Context
Insider transactions are closely monitored as they can provide insights into management's perspective on the company's valuation and future prospects. This transaction reflects the standard practice of using stock-based compensation to incentivize executives.
Comparison to Industry Standards
- Restricted stock awards are a common form of executive compensation in the healthcare industry, aligning management's interests with shareholder value.
- Companies like HCA Healthcare and Tenet Healthcare also utilize similar equity-based compensation plans for their executives.
Stakeholder Impact
- The transaction could have a minor positive impact on shareholder sentiment, as it signals confidence from a key executive.
Key Dates
| Date | Description |
|---|---|
| 09/01/2024 | Date of the transaction (acquisition of shares) and grant date of the restricted stock award. |
| 09/01/2025 | First anniversary of the grant date, when the first installment of the RSAs vests. |
| 09/04/2024 | Date the Form 4 was signed and reported. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.